Murali Doraiswamy is a world leader in the fields of cognitive neuroscience and neuropsychiatry. His research unit has been involved in the development of many of the leading products used today to treat neurological and psychiatric conditions such as Alzheimer’s disease. Murali is a Fellow of the Royal College of Physicians, a Fellow of the American Neurological Association, and a member of the World Economic Forum’s Global Agenda Council on Neuroscience and Behavior. He also serves as an adviser to leading government agencies, biotech and digital health companies, and patient advocacy groups.